Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Leukemia, Myeloid, Acute 196 Myelodysplastic Syndromes 128 Precursor Cell Lymphoblastic Leukemia-Lymphoma 123 Leukemia, Lymphocytic, Chronic, B-Cell 102 Leukemia 102 Lymphoma 86 Multiple Myeloma 81 Lymphoma, Non-Hodgkin 80 Hematologic Neoplasms 65 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 62 Hodgkin Disease 62 Recurrence 52 Lymphoma, B-Cell 40 Lymphoma, Mantle-Cell 39 Myeloproliferative Disorders 36 Lymphoma, Follicular 35 Melanoma 34 Lymphoma, Large B-Cell, Diffuse 31 Burkitt Lymphoma 31 Graft vs Host Disease 28 Neoplasms, Plasma Cell 24 Primary Myelofibrosis 23 Ovarian Neoplasms 23 Lymphoma, B-Cell, Marginal Zone 23 Anemia, Refractory, with Excess of Blasts 21 Leukemia, Myelomonocytic, Chronic 20 Leukemia, Biphenotypic, Acute 17 Lymphoma, T-Cell 16 Neuroblastoma 15 Neoplasms 14

Interventions

Everolimus 3 Capecitabine 3 lutetium Lu 177 dotatate 2 lenvatinib 2 cabozantinib 2 Thyroidectomy 2 Temozolomide 2 Sorafenib 2 Magnetic Resonance Spectroscopy 2 High-Energy Shock Waves 2 veliparib 1 vatalanib 1 vandetanib 1 temsirolimus 1 selpercatinib 1 sacubitril and valsartan sodium hydrate drug combination 1 ponatinib 1 pentetreotide 1 pasireotide 1 gallium Ga 68 dotatate 1 fluorodopa F 18 1 fludarabine 1 cemiplimab 1 Vinorelbine 1 Thalidomide 1 Surgical Procedures, Operative 1 Sunitinib 1 Specimen Handling 1 Sirolimus 1 Semaxinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Carcinoma, Medullary × fludarabine × Clear all

NCT04877613 2025-07-03

GFRα4 CAR T Cells in MTC Patients

University of Pennsylvania

Phase 1 Active not recruiting

Carcinoma, Medullary

Data powered by HemOnc (CC BY 4.0) Colophon ⚡